超声诱导空化与被动声学成像:SonoTran平台在大动物模型中的性能与短期安全性
在大动物模型中评估SonoTran平台(专用超声设备加空化核颗粒)触发、检测并实时被动声学成像空化事件的能力与安全性;空化可在不同组织深度和器官安全触发并成像,输注SonoTran颗粒未见不良反应,超声诱导空化在可临床靶向器官(如肝脏)长达1小时内未造成组织损伤。
要点
- SonoTran系统可实时触发、检测并被动声学成像空化事件。
- 空化可在不同组织深度和不同器官安全触发并成像。
- 输注SonoTran颗粒未见不良反应,肝脏等靶向器官1小时内未见空化相关组织损伤。
核心结论
- SonoTran系统具备空化触发与监测性能,在大动物模型中受控空化具有安全性。
研究设计与样本
- 大动物模型研究,使用临床就绪的SonoTran平台系统(SonoTran System超声设备加SonoTran Particles空化核颗粒),通过被动声学成像实时触发、检测和显示空化事件。
关键影像表现/征象
- 空化可在不同组织深度和不同器官被安全触发并被动声学成像。
- 超声诱导空化在可临床靶向器官(如肝脏)长达1小时内未造成组织损伤。
临床应用与阅片要点
- SonoTran系统可实时被动声学成像显示空化事件,用于监测超声诱导空化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ultrasound-induced cavitation is currently under investigation for several potential applications in cancer treatment. Among these, the use of low-intensity ultrasound, coupled with the systemic administration of various cavitation nuclei, has been found to enhance the delivery of co-administered therapeutics into solid tumors. Effective pharmacological treatment of solid tumors is often hampered, among various factors, by the limited diffusion of drugs from the bloodstream into the neoplastic mass and through it, and SonoTran holds the potential to tackle this clinical limitation by increasing the amount of drug and its distribution within the ultrasound-targeted tumor tissue. Here we use a clinically ready system (SonoTran Platform) composed of a dedicated ultrasound device (SonoTran System) capable of instigating, detecting and displaying cavitation events in real time by passive acoustic mapping and associated cavitation nuclei (SonoTran Particles), to instigate cavitation in target tissues and illustrate its performance and safety in a large-animal model. This study found that cavitation can be safely triggered and mapped at different tissue depths and in different organs. No adverse effects were associated with infusion of SonoTran Particles, and ultrasound-induced cavitation caused no tissue damage in clinically targetable organs (e.g., liver) for up to 1 h. These data provide evidence of cavitation initiation and monitoring performance of the SonoTran System and the safety of controlled cavitation in a large-animal model using a clinic-ready platform technology.
引用
- Masiero, Boulos, Crake, et al. Ultrasound-induced cavitation and passive acoustic mapping: SonoTran platform performance and short-term safety in a large-animal model. Ultrasound Med Biol. 2022. PMID: 35577660. doi:10.1016/j.ultrasmedbio.2022.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。